TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/23 08:00 | 8/15/23 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weisman Harlan F | TX | DO | P,CEO | P | 150 | 0.2500 | 0 | 600 | 280 | 815 | D | ||||||||||||||
3/13/23 08:00 | 3/10/23 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weisman Harlan F | TX | DO | P,CEO | P | 132 | 0.8789 | 0 | 150 | 232 | 215 | D | ||||||||||||||
12/19/22 08:00 | 12/15/22 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weisman Harlan F | TX | DO | P,CEO | P | 53 | 1.06 | 0 | 50 | 342 | 65 | D | ||||||||||||||
5/20/22 17:17 | 5/18/22 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weisman Harlan F | TX | D | P.m | 38 | 5.37 | 0 | 7 | 95 | 15 | D | |||||||||||||||
5/17/22 21:55 | 5/16/22 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weisman Harlan F | TX | D | P | 12 | 4.74 | 0 | 3 | 50 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |